Insulet (PODD)
(Delayed Data from NSDQ)
$239.01 USD
+0.04 (0.02%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $239.00 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Insulet (PODD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$238.74 | $285.00 | $185.00 | -0.10% |
Price Target
Based on short-term price targets offered by 19 analysts, the average price target for Insulet comes to $238.74. The forecasts range from a low of $185.00 to a high of $285.00. The average price target represents a decline of 0.1% from the last closing price of $238.97.
Analyst Price Targets (19)
Broker Rating
Insulet currently has an average brokerage recommendation (ABR) of 1.35 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms. The current ABR compares to an ABR of 1.35 a month ago based on 20 recommendations.
Of the 20 recommendations deriving the current ABR, 16 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 5% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 16 | 16 | 16 | 16 | 16 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.35 | 1.35 | 1.35 | 1.35 | 1.35 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
8/12/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Hold | Hold |
8/9/2024 | BTIG | Marie Thibault | Not Available | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | UBS | Danielle Antalffy | Hold | Hold |
8/8/2024 | Not Identified | Not Identified | Hold | Hold |
8/8/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
6/3/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
5/30/2024 | Atlantic Equities | Issie Kirby | Not Available | Strong Buy |
5/28/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
5/10/2024 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
5/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/10/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
5/10/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
3/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.35 |
ABR (Last week) | 1.35 |
# of Recs in ABR | 20 |
Average Target Price | $238.74 |
LT Growth Rate | 17.60% |
Industry | Medical - Products |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | 0.78 |
PODD FAQs
Insulet Corporation (PODD) currently has an average brokerage recommendation (ABR) of 1.35 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms.
The average price target for Insulet Corporation (PODD) is $238.74. The current on short-term price targets is based on 9 reports.
The forecasts for Insulet Corporation (PODD) range from a low of $185 to a high of $285. The average price target represents a decline of $0.10 from the last closing price of $238.97.
The current DOWNSIDE for Insulet Corporation (PODD) is 0.10%
Based on short-term price targets offered by 19 analysts, the average price target for Insulet comes to $238.74. The forecasts range from a low of $185.00 to a high of $285.00. The average price target represents a decline of 0.1% from the last closing price of $238.97.